Camargo names VP, global program management
This article was originally published in Scrip
Cincinnati-based Camargo Pharmaceutical Services, a global strategist in the drug development industry specializing in the 505(b)(2) approval pathway, has appointed Jason Moore vice-president of global program management. Mr Moore will be responsible for enhancing Camargo's project management process from proposals through project completion, which will be key to helping Camargo create the capacity to meet increasing client demands. Before joining Camargo, Mr Moore was vice-president at PLx Pharma for seven years, where he led all regulatory affairs functions and product submissions for five active investigational new drugs and one approved new drug application.
You may also be interested in...
A steady flow of venture capital into the medical device industry continued in the first half of 2020 despite the novel coronavirus pandemic. While Biopharma companies secured more than $7.5bn in private financings between January and June.
Experts discuss the future of brain health, changing the stereotypical view of an Alzheimer’s patient and how technology and science have evolved the treatment possibilities for dementia patients in 2020 – even if ‘clinical practice is taking a long time to catch up.’
A complete response letter from the FDA in June knocked Intercept’s stock price down to 2014 levels, but perhaps the regulator is sending wider messages about NASH.